Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1681008/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849735193928138752 |
|---|---|
| author | Jinpeng Li Jinpeng Li Yuanming Li Jingtao Zhong Jiasheng Du Jiao Chen Jutian Shi Lujun Zhao Jinlong Song |
| author_facet | Jinpeng Li Jinpeng Li Yuanming Li Jingtao Zhong Jiasheng Du Jiao Chen Jutian Shi Lujun Zhao Jinlong Song |
| author_sort | Jinpeng Li |
| collection | DOAJ |
| format | Article |
| id | doaj-art-e1ea6bc3a6a24a95b4af7472dd577f6c |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-e1ea6bc3a6a24a95b4af7472dd577f6c2025-08-20T03:07:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.16810081681008Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulasJinpeng Li0Jinpeng Li1Yuanming Li2Jingtao Zhong3Jiasheng Du4Jiao Chen5Jutian Shi6Lujun Zhao7Jinlong Song8Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaInterventional Vascular Department, Laizhou Hospital of Traditional Chinese Medicine, Laizhou, Shandong, ChinaDepartment of Hepatobiliary Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaGraduate Department of Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaDepartment of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, ChinaDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, ChinaDepartment of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1681008/fullhepatocellular carcinomahigh-flow hepatic arteriovenous fistulahepatic arterial infusion chemotherapyimmune checkpoint inhibitorstyrosine kinase inhibitors |
| spellingShingle | Jinpeng Li Jinpeng Li Yuanming Li Jingtao Zhong Jiasheng Du Jiao Chen Jutian Shi Lujun Zhao Jinlong Song Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas Frontiers in Immunology hepatocellular carcinoma high-flow hepatic arteriovenous fistula hepatic arterial infusion chemotherapy immune checkpoint inhibitors tyrosine kinase inhibitors |
| title | Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas |
| title_full | Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas |
| title_fullStr | Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas |
| title_full_unstemmed | Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas |
| title_short | Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas |
| title_sort | correction triple therapy revolutionizes treatment paradigms for previously untreatable hcc complicated by high flow hepatic arteriovenous fistulas |
| topic | hepatocellular carcinoma high-flow hepatic arteriovenous fistula hepatic arterial infusion chemotherapy immune checkpoint inhibitors tyrosine kinase inhibitors |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1681008/full |
| work_keys_str_mv | AT jinpengli correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jinpengli correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT yuanmingli correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jingtaozhong correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jiashengdu correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jiaochen correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jutianshi correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT lujunzhao correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas AT jinlongsong correctiontripletherapyrevolutionizestreatmentparadigmsforpreviouslyuntreatablehcccomplicatedbyhighflowhepaticarteriovenousfistulas |